pd 98059 has been researched along with Colonic Diseases in 1 studies
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.
Colonic Diseases: Pathological processes in the COLON region of the large intestine (INTESTINE, LARGE).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chandrakesan, P | 1 |
| Ahmed, I | 1 |
| Anwar, T | 1 |
| Wang, Y | 1 |
| Sarkar, S | 1 |
| Singh, P | 1 |
| Peleg, S | 1 |
| Umar, S | 1 |
1 other study available for pd 98059 and Colonic Diseases
| Article | Year |
|---|---|
Novel changes in NF-{kappa}B activity during progression and regression phases of hyperplasia: role of MEK, ERK, and p38.
Topics: Animals; Chemokine CXCL1; Citrobacter rodentium; Colon; Colonic Diseases; Enterobacteriaceae Infecti | 2010 |